Aravive
developing transformative targeted cancer therapeutics | Aravive
Company
Deck Type
Sector
Industry
Deck date
September 2022
Slide
1 of 39
Related slides by other companies
AN2 Therapeutics
IPO
March 2022
an therapeutics developing treatments for rare chronic and serious infectious diseases with high unmet needs | AN2 Therapeutics
AN2 Therapeutics
IPO
March 2022
an therapeutics developing treatments for rare chronic and serious infectious diseases with high unmet needs | AN2 Therapeutics
Fusion Pharmaceuticals
IPO
June 2020
chief scientific james chief medical officer officer fusion lead program targeted alpha therapeutic | Fusion Pharmaceuticals
Revelation Biosciences
Investor Presentation
October 2022
revelation developing innovative therapeutics to address unmet needs | Revelation Biosciences
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights